Drugs / clomifen citrat
last change Jan 2026 re-read 3 minutes ago

clomifen citrat

Developed for
polycystic ovary syndrome
Investigated by
Inlacinpenelitian

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07403201 Dec 2021 → Jan 2026 overdue polycystic ovary syndrome Inlacinpenelitian Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as clomifen citrat ClinicalTrials.gov intervention name — accepted as the source's own label NCT07403201 ↗